News

You are here

INJECT-ID
Novosanis receives grant from Interreg CrossCare to build a next-generation of its unique and patented intradermal drug delivery device, VAX-ID, in collaboration with living labs Happy...
Royal Mission Mexico
A wrap to an exciting and eventful week! Our Product designer, Alejandra Ríos Cortés, represented Novosanis at the Royal Mission, an initiative led by Princess Astrid of Belgium, to boost...
HPV Vaccination Impact Study Rwanda
Today, 4 February, is #worldcancerday. Cervical cancer is one of the most preventable forms of cancer if it’s detected early. HPV urine testing can offer a solution for screening next to...
Novosanis, een Belgisch MedTech en spin-off bedrijf van de Universiteit Antwerpen dat werd opgericht in 2013, maakte vandaag bekend dat het werd overgenomen door het Amerikaanse...

Pages